
Pajson Agro India IPO Listing at 5% Premium at ₹124 Per Share
Posted by : sachet | Thu Dec 18 2025

Pajson Agro India IPO listing: The Pajson Agro India IPO was subscribed 6.05 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 10.92 times, and non-institutional investors (NIIs) received 6.86 times. The retail quota of the issue was subscribed to 33.24%. Before delving deeper into the topic, go through the details of the Pajson Agro India IPO.
Pajson Agro India IPO
It is a book-building issue of ₹74.45 crore shares. The issue is entirely a fresh issue of 0.33 crore shares. The IPO is expected to be listed on the BSE and SME with a tentative listing date of 18th December 2025. The Vidya Wires IPO is expected to take place from 11th December 2025 to 15th December 2025. The face value of Vidya Wires IPO shares is ₹10 per share, and the IPO price is set at ₹118 per share.
| IPO Allotment Date | 16th December 2025 |
| IPO Open Date | 11th December 2025 |
| IPO Close Date | 15th December 2025 |
| Refund Initiation | 17th December 2025 |
| Issue Size | 63,09,600 shares(agg. up to ₹74.45 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 1,200 Shares |
| Issue Price | ₹118 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | 18th December 2025 |
Pajson Agro India IPO Listing
On the BSE & SME platforms, Pajson Agro India shares are listed at ₹124 per share, reflecting a 5.08% premium over the issue price of ₹118 per share. On the other hand, on the BSE & SME platform, shares are listed at ₹124 per share, reflecting a premium of ₹6 from their issue price of ₹118 per share.
About the Pajson Agro India IPO
Pajson Agro India was established in 2021 and processes raw cashew nuts into cashew kernels, supplying them to domestic and international markets. The company sell in bulk and also in retail packs under our white-label brand Royal Mewa (dry fruits segment). Further, it sells by-products (cashew husk and shells) for industrial and agricultural use. Sales and Distribution Channels: Sales operate through four verticals: 1. Wholesale Mandis (Local markets), 2. Institutional Sales (to retail chains, food brands, etc.), exports and B2C/Royal Mewa brand. Currently, the company operates in 18 states and 3 Union Territories of India. It has a cashew processing plant in Visakhapatnam, Anakapalli, Andhra Pradesh, across 295,990.20 square feet with a capacity of 18,000 metric tonnes. Also, it has a dedicated packaging unit. Its processing facility includes shelling, peeling, cleaning, grading, sorting, and related handling equipment. As of July 31, 2025, it has 465 permanent employees.
Pajson Agro India Limited Financials
The company’s financial analysis is essential before applying for Pajson Agro India Limited’s IPO. Refer to the table to learn about Vidya Wires Limited’s financial information.
| Year Ended | 30th Sep 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 | 31st March 2023 |
| Assets | 151.63 | 65.73 | 55.39 | 50.17 |
| Revenue | 118.37 | 187.28 | 96.04 | 101.13 |
| Profit After Tax | 14.20 | 20.42 | 3.35 | 0.02 |
| EBITDA | 21.07 | 30.27 | 5.74 | 1.10 |
| Net Worth | 58.40 | 44.21 | 23.79 | 20.44 |
| Reserves and Surplus | 40.90 | 40.71 | 20.29 | 16.94 |
| Total Borrowings | 40.04 | 14.57 | 14.57 | 0.00 |
Explanation
Pajson Agro India Limited’s revenue increased by 95% from ₹96.04 crores in March 2024 to ₹187.28 crores in March 2025. Moreover, the company’s PAT increased by 509% from ₹3.35 crores in March 2024 to ₹20.42 crores in March 2025.
Recent Articles
Best Penny Stocks for Long Term in India | Penny Stocks in 2025
Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY
Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY
Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY
Related Posts
Shyam Dhani Industries IPO GMP & Review: Apply or Avoid?
Dachepalli Publishers IPO GMP & Review: Apply or Avoid?
Phytochem Remedies IPO Allotment Status Check Online: GMP, Subscription, Price, and More
KSH International IPO Listing Preview: What to Expect Now?
HRS Aluglaze IPO Listing at 31% Premium at ₹126 Per Share

